Delivery Order SPE2DB22D3401-SPE2DB24FT2KH
- Not listed
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical company. The contract is for the provision of REMICADE 100 MG VIALS, with a potential value of $7,706.41 and a period of performance through January 26, 2024. This award is not associated with any set-aside program. Amerisourcebergen Drug Corp is the prime contractor on this...
- The U.S. Defense Logistics Agency (DLA) awarded a $34,436.74 Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp for the supply of 4565677215 REMICADE 100 MG VIALS. This contract, which does not have a set-aside designation, has a period of performance through September 5, 2024. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is the prime contractor for this award. This Delivery Order contract is part of a larger Indefinite Delivery Contract (IDC) with the...
- This $12,330.24 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4,565,440,341 units of Remicade 100 mg vials, a specialty pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical for the delivery of a comprehensive range of medical commodities to support military treatment...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $13,515.84, is for the provision of 4,564,202,664 units of the pharmaceutical product REMICADE 100 MG VIALS. The contract has an ultimate completion date of April 9, 2024. Amerisourcebergen Drug Corporation holds an indefinite delivery contract (IDC) with a potential...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,024.40 firm fixed-price delivery order is for the provision of REMICADE 100 MG VIALS, a specialty medication. The contract has an ultimate completion date of March 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $2,568.80 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 100 mg vials of the drug Remicade. The contract has an ultimate completion date of September 4, 2024. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of REMICADE 100 MG VIALS. The contract has a ceiling value of $35,458.10 and is a firm fixed price delivery order that runs through August 8, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of...
- The Defense Logistics Agency awarded a delivery order valued at $3,579.64 to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials. This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of November 14, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order falls under AmerisourceBergen's broader Indefinite...
- This is a $24,787.38 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 100 mg vials of the pharmaceutical product Remicade. The contract has an ultimate completion date of September 5, 2024. AmerisourceBergen is one of the largest pharmaceutical distributors in the United States and has been awarded numerous federal contracts to provide a wide range of pharmaceutical and medical supplies to support military treatment...
- The Defense Logistics Agency awarded a delivery order valued at $17,318.52 to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials, with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement and reflects the agency's ongoing pharmaceutical supply needs for military healthcare operations. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB24FT2KHDelivery Order
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4,564,097,643 units of REMICADE 100 mg vials. The $3,179.58 contract has a period of performance through March 28, 2024 and does not have a set-aside designation. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle for AmerisourceBergen to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 3/27/24 |